Cargando…
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions
Tumor cells are characterized by overexpressed tumor-associated antigens or mutated neoantigens, which are expressed on the cell surface or intracellularly. One strategy of cancer immunotherapy is to target cell-surface-expressed tumor-associated antigens (TAAs) with therapeutic antibodies. For targ...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326752/ https://www.ncbi.nlm.nih.gov/pubmed/35892709 http://dx.doi.org/10.3390/antib11030049 |